CV Therapeutics to Announce 2008 First Quarter Financial Results on Friday, April 25, 2008
April 14 2008 - 5:01PM
PR Newswire (US)
PALO ALTO, Calif., April 14 /PRNewswire-FirstCall/ -- CV
Therapeutics, Inc. (NASDAQ:CVTX) today announced that it will
release first quarter financial results for 2008 before the market
opens on Friday, April 25, 2008. Company management will webcast a
conference call at 8:30 a.m. EDT, 5:30 a.m. PDT, on the company's
website. To access the live webcast, please log on to the Company's
website at http://www.cvt.com/ and go to the Investor Information
section. Alternatively, domestic callers may participate in the
conference call by dialing (866) 524-6241, and international
callers may participate in the conference call by dialing (706)
679-3061. Webcast and telephone replays of the conference call will
be available approximately two hours after the completion of the
call through Friday, May 2, 2008. Domestic callers can access the
replay by dialing (800) 642-1687, and international callers can
access the replay by dialing (706) 645-9291; the PIN access number
is 43615588. About CV Therapeutics CV Therapeutics, Inc.,
headquartered in Palo Alto, California, is a biopharmaceutical
company primarily focused on applying molecular cardiology to the
discovery, development and commercialization of novel, small
molecule drugs for the treatment of cardiovascular diseases. CV
Therapeutics' approved products include Ranexa(R) (ranolazine
extended- release tablets), indicated for the treatment of chronic
angina in patients who have not achieved an adequate response with
other antianginal drugs, and Lexiscan(TM) (regadenoson) injection
for use as a pharmacologic stress agent in radionuclide myocardial
perfusion imaging studies in patients unable to undergo adequate
exercise stress. CV Therapeutics also has other clinical and
preclinical drug development candidates and programs. DATASOURCE:
CV Therapeutics, Inc. CONTACT: John Bluth, Executive Director,
Corporate Communications and Investor Relations of CV Therapeutics,
+1-650-384-8850 Web site: http://www.cvt.com/
http://www.ranexa.com/ http://www.lexiscan.com/
Copyright
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jul 2023 to Jul 2024